BoomRay Pharmaceuticals Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $44.7M

  • Investors
  • 6

BoomRay Pharmaceuticals General Information

Description

Developer and clinical researcher of radionuclide targeted drugs designed for oncology. Having constructed a radionuclide drug development and transformation platform, the company focuses on accurate diagnosis and treatment of tumors, providing oncologist with advanced treatment solutions.

Contact Information

Website
www.boomray.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 7
  • No. 19, Yong'an Road
  • Suzhou, Jiangsu 215011
  • China
+86 133
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Building 7
  • No. 19, Yong'an Road
  • Suzhou, Jiangsu 215011
  • China
+86 133

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BoomRay Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Jul-2022 $44.7M Completed Generating Revenue
1. Early Stage VC 07-Jun-2022 Completed Generating Revenue
To view BoomRay Pharmaceuticals’s complete valuation and funding history, request access »

BoomRay Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer and clinical researcher of radionuclide targeted drugs designed for oncology. Having constructed a radionuclid
Biotechnology
Suzhou, China

Beijing, China
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BoomRay Pharmaceuticals Competitors (15)

One of BoomRay Pharmaceuticals’s 15 competitors is Mabworks Biotech, a Venture Capital-Backed company based in Beijing, China.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mabworks Biotech Venture Capital-Backed Beijing, China
Helocyte Venture Capital-Backed New York, NY
GMAX Bio Venture Capital-Backed Hangzhou, China
Variant Bio Venture Capital-Backed Seattle, WA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 15 competitors. Get the full list »

BoomRay Pharmaceuticals Patents

BoomRay Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026209056-A1 Bicyclic peptide radionuclide ligand and chelate Pending 03-Apr-2025
WO-2026114399-A1 Bicyclic peptide radionuclide ligand and chelate Pending 29-Nov-2024
WO-2026041108-A1 Compound based on cyclic peptide and covalent warhead and use thereof Pending 23-Aug-2024
WO-2026041109-A1 Fibroblast activation protein inhibitor and use thereof Pending 23-Aug-2024
WO-2026007871-A1 Inhibitor targeting fibroblast activation protein Pending 01-Jul-2024
To view BoomRay Pharmaceuticals’s complete patent history, request access »

BoomRay Pharmaceuticals Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Chengdu Tianfu Sanjiang Asset Management Venture Capital Minority
HSG (Hong Kong) Venture Capital Minority
Puhua Capital Venture Capital Minority
Shenzhen Jinsheng Equity Investment Management Growth/Expansion Minority
Tsing Song Capital Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

BoomRay Pharmaceuticals FAQs

  • When was BoomRay Pharmaceuticals founded?

    BoomRay Pharmaceuticals was founded in 2018.

  • Where is BoomRay Pharmaceuticals headquartered?

    BoomRay Pharmaceuticals is headquartered in Suzhou, China.

  • What industry is BoomRay Pharmaceuticals in?

    BoomRay Pharmaceuticals’s primary industry is Biotechnology.

  • Is BoomRay Pharmaceuticals a private or public company?

    BoomRay Pharmaceuticals is a Private company.

  • What is BoomRay Pharmaceuticals’s current revenue?

    The current revenue for BoomRay Pharmaceuticals is .

  • How much funding has BoomRay Pharmaceuticals raised over time?

    BoomRay Pharmaceuticals has raised $52.2M.

  • Who are BoomRay Pharmaceuticals’s investors?

    Chengdu Tianfu Sanjiang Asset Management, HSG (Hong Kong), Puhua Capital, Shenzhen Jinsheng Equity Investment Management, and Tsing Song Capital are 5 of 6 investors who have invested in BoomRay Pharmaceuticals.

  • Who are BoomRay Pharmaceuticals’s competitors?

    Mabworks Biotech, Helocyte, GMAX Bio, Variant Bio, and CytomX Therapeutics are some of the 15 competitors of BoomRay Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process